Success Advance Trading Pharmaceutical Import Profile — Malaysia (DGFT 2022–2026)

Name: Success Advance Trading Pharmaceutical Import Records from India — 3 Products, $39.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Success Advance Trading — Pharmaceutical Importer Profile (2026) | 3 Products, $39.6K Trade | TransData Nexus

Success Advance Trading

Pharmaceutical Importer · Malaysia · Ayurvedic & Herbal Products Focus · $39.6K Total Trade · DGFT Verified

Success Advance Trading is a pharmaceutical importer based in Malaysia with a total trade value of $39.6K across 3 products in 1 therapeutic categories. Based on 6 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Success Advance Trading sources from 1 verified Indian supplier, with Unicorn Exports accounting for 100.0% of imports.

Success Advance Trading — Import Portfolio & Supplier Network

Success Advance Trading import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Success Advance Trading?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Unicorn Exports	$13.2K	2	100.0%

Success Advance Trading sources from 1 verified Indian supplier across 1 distinct formulations. The sourcing is highly concentrated — Unicorn Exports accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Success Advance Trading Import?

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Asava	Ayurvedic & Herbal Products	$13.2K	2	2.9%	6
2	Ghrita	Ayurvedic & Herbal Products	$13.2K	2	2.9%	3
3	Kwatha	Ayurvedic & Herbal Products	$13.2K	2	2.5%	12

Success Advance Trading imports 3 pharmaceutical products across 1 categories into Malaysia totaling $39.6K.

Success Advance Trading — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Success Advance Trading is a Malaysian pharmaceutical importer and buyer specializing in the acquisition of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Headquartered at No. 39C, Jalan Hulubalang 26, Taman Sentosa, 41200 Klang, Selangor, Malaysia, the company plays a pivotal role in the Malaysian pharmaceutical distribution network by sourcing and importing a diverse range of pharmaceutical products.

The company's import activities are primarily focused on finished pharmaceutical formulations, indicating a strategic emphasis on ready-to-market products. This approach suggests a streamlined supply chain, enabling efficient distribution within Malaysia's healthcare sector. By concentrating on finished products, Success Advance Trading aligns with the regulatory requirements set forth by Malaysia's Drug Control Authority (DCA), ensuring compliance and facilitating smoother market entry for imported pharmaceuticals. (npra.gov.my)

2Distribution Network

Success Advance Trading's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across Malaysia. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, the company's operations are centered in Klang, Selangor, a region renowned for its robust logistics infrastructure and proximity to major ports. This strategic positioning facilitates swift distribution to various healthcare facilities, including hospitals, clinics, and pharmacies, throughout Malaysia. The company's focus on importing finished pharmaceutical formulations further streamlines its logistics operations, reducing lead times and enhancing the reliability of its supply chain.

3Industry Role

In Malaysia's pharmaceutical supply chain, Success Advance Trading functions as a primary wholesaler and importer. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company ensures a steady supply of essential medications to the Malaysian market. This role is crucial in bridging the gap between international pharmaceutical manufacturers and local healthcare providers, thereby contributing to the accessibility and affordability of medicines within Malaysia. The company's operations are in compliance with Malaysia's regulatory framework, including the Control of Drugs and Cosmetics Regulations 1984, which mandates that all pharmaceutical products imported into the country be registered with the Drug Control Authority (DCA). (npra.gov.my)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Success Advance Trading

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Success Advance Trading's sourcing strategy exhibits a high degree of concentration, with a total import value of $40,000 USD from India over six shipments, focusing on three products across a single therapeutic category. This concentrated sourcing approach indicates a strategic decision to specialize in specific products, potentially leveraging established relationships with suppliers to ensure consistent quality and supply. However, this dependency on a single supplier, Unicorn Exports, for all shipments, introduces a risk of supply chain disruption in the event of unforeseen issues such as production delays, regulatory changes, or geopolitical tensions affecting trade routes. The absence of alternative suppliers for these products suggests a need for diversification to mitigate potential risks and enhance supply chain resilience.

2Supply Chain Resilience

The resilience of Success Advance Trading's supply chain is currently limited due to its reliance on a single supplier, Unicorn Exports, for all imported pharmaceutical products. This lack of supplier diversification poses a significant risk, as any disruption at the supplier's end could lead to immediate shortages in the Malaysian market. Additionally, the company's focus on a narrow range of products within a single therapeutic category further constrains its ability to adapt to changing market demands or supply chain disruptions. To enhance resilience, it is advisable for Success Advance Trading to consider diversifying its supplier base and expanding its product portfolio, thereby reducing dependency on a single source and improving its capacity to respond to market fluctuations and potential disruptions.

Importing Pharmaceuticals into Malaysia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Malaysia

1Regulatory Authority & Framework

In Malaysia, the National Pharmaceutical Regulatory Agency (NPRA), operating under the Ministry of Health (MOH), serves as the primary regulatory authority overseeing the pharmaceutical sector. The NPRA is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products through the registration and monitoring of drugs. The regulatory framework governing pharmaceutical imports is primarily defined by the Control of Drugs and Cosmetics Regulations 1984, which mandates that all pharmaceutical products imported into Malaysia be registered with the Drug Control Authority (DCA). This registration process involves a comprehensive evaluation of the product's quality, safety, and efficacy before it can be marketed within the country. (npra.gov.my)

2Import Licensing & GMP

To import pharmaceutical products into Malaysia, companies must obtain an Import Licence (Lesen Mengimport) from the NPRA. This licence authorizes the holder to import and sell registered pharmaceutical products within Malaysia. Additionally, the imported products must be manufactured in facilities that comply with Good Manufacturing Practice (GMP) standards recognized by the NPRA. The NPRA accepts GMP certifications from various international bodies, including the World Health Organization (WHO), the Pharmaceutical Inspection Co-operation Scheme (PIC/S), and the European Union (EU). This recognition ensures that imported pharmaceutical products meet international quality standards, thereby safeguarding public health. (npra.gov.my)

Success Advance Trading — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Success Advance Trading's focus on importing Ayurvedic and herbal products, specifically Asava, Ghrita, and Kwatha, indicates a strategic alignment with the growing demand for traditional and natural remedies in Malaysia. The therapeutic category of Ayurvedic and herbal products offers a niche market with consumers seeking alternative treatments. The company's import strategy is likely driven by consumer preferences for natural health solutions and the increasing acceptance of alternative medicine within Malaysia's diverse cultural landscape. By concentrating on this therapeutic area, Success Advance Trading positions itself to cater to a specific segment of the Malaysian healthcare market, potentially differentiating itself from competitors focusing on conventional pharmaceuticals.

2Sourcing Profile

Success Advance Trading's sourcing strategy is characterized by a focus on finished pharmaceutical formulations, particularly Ayurvedic and herbal products, imported from India. This approach suggests a preference for ready-to-market products that align with consumer demand for natural remedies. The company's reliance on a single supplier, Unicorn Exports, for all its imports indicates a strategic decision to maintain consistency in product quality and supply. However, this concentrated sourcing strategy also exposes the company to potential risks associated with supplier dependency, such as supply chain disruptions or changes in supplier capabilities.

Seller's Guide — How to Become a Supplier to Success Advance Trading

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Success Advance Trading, especially those offering Ayurvedic and herbal products that align with the company's current import focus. Diversifying the supplier base could mitigate risks associated with supplier dependency and enhance the resilience of Success Advance Trading's supply chain. Additionally, expanding the product portfolio to include a broader range of therapeutic categories could enable the company to tap into new market segments and respond more effectively to evolving consumer preferences in Malaysia.

2Requirements & Qualifications

Indian exporters seeking to supply Success Advance Trading must ensure that their products are registered with the Drug Control Authority (DCA) in Malaysia and manufactured in facilities compliant with recognized Good Manufacturing Practice (GMP) standards. Additionally, products must meet Malaysia's labeling requirements

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Success Advance Trading

What products does Success Advance Trading import from India?

Success Advance Trading imports 3 pharmaceutical products across 1 categories. Top imports: Asava ($13.2K), Ghrita ($13.2K), Kwatha ($13.2K).

Who supplies pharmaceuticals to Success Advance Trading from India?

Success Advance Trading sources from 1 verified Indian suppliers. The primary supplier is Unicorn Exports (100.0% of imports, $13.2K).

What is Success Advance Trading's total pharmaceutical import value?

Success Advance Trading's total pharmaceutical import value from India is $39.6K, based on 6 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Success Advance Trading focus on?

Success Advance Trading imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full Success Advance Trading Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.